Annals of Allergy Asthma & Immunology最新文献

筛选
英文 中文
Managing Anaphylaxis in Patients on Beta-Blockers: Case Insights and Practical Considerations. 管理过敏反应的患者β受体阻滞剂:案例的见解和实际考虑。
IF 5.8 2区 医学
Annals of Allergy Asthma & Immunology Pub Date : 2025-07-07 DOI: 10.1016/j.anai.2025.06.031
Dayna Miyashiro, Edsel M Abud, Kevin A Cook, Andrew A White
{"title":"Managing Anaphylaxis in Patients on Beta-Blockers: Case Insights and Practical Considerations.","authors":"Dayna Miyashiro, Edsel M Abud, Kevin A Cook, Andrew A White","doi":"10.1016/j.anai.2025.06.031","DOIUrl":"https://doi.org/10.1016/j.anai.2025.06.031","url":null,"abstract":"","PeriodicalId":50773,"journal":{"name":"Annals of Allergy Asthma & Immunology","volume":" ","pages":""},"PeriodicalIF":5.8,"publicationDate":"2025-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144602170","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
One-Bag Protocol for Cancer Drug Hypersensitivity: A Meta-Analysis of Safety and Effectiveness. 癌症药物过敏的一袋方案:安全性和有效性的荟萃分析。
IF 5.8 2区 医学
Annals of Allergy Asthma & Immunology Pub Date : 2025-07-05 DOI: 10.1016/j.anai.2025.06.034
Andrés Noyola-Perez, Sandra N González-Diaz, Carlos Macouzet-Sánchez, Jesús M Alanís-Alvarez, Valeria Muñoz-Silva, Rosa I Guzmán-Avilán, Alejandra Macias-Weinmann, Cindy E De Lira-Quezada, Natalhie Acuña-Ortega, Mário Morais-Almeida, Ignacio J Ansotegui
{"title":"One-Bag Protocol for Cancer Drug Hypersensitivity: A Meta-Analysis of Safety and Effectiveness.","authors":"Andrés Noyola-Perez, Sandra N González-Diaz, Carlos Macouzet-Sánchez, Jesús M Alanís-Alvarez, Valeria Muñoz-Silva, Rosa I Guzmán-Avilán, Alejandra Macias-Weinmann, Cindy E De Lira-Quezada, Natalhie Acuña-Ortega, Mário Morais-Almeida, Ignacio J Ansotegui","doi":"10.1016/j.anai.2025.06.034","DOIUrl":"https://doi.org/10.1016/j.anai.2025.06.034","url":null,"abstract":"<p><strong>Background: </strong>Hypersensitivity reactions (HSRs) to essential chemotherapy create treatment barriers in cancer care globally. Conventional three-bag protocols (3BP) for rapid drug desensitization (RDD) present operational challenges that may inadvertently exacerbate healthcare disparities.</p><p><strong>Objective: </strong>We aimed to systematically evaluate the safety, completion rates, and procedural duration of 1BP for chemotherapy and monoclonal antibody HSRs, and to compare these outcomes with those of conventional 3BP.</p><p><strong>Methods: </strong>In this meta-analysis, we searched MEDLINE, Embase, Web of Science, and CENTRAL. We included studies describing 1BP for HSRs to chemotherapy and monoclonal antibodies. Four reviewers independently screened the studies and extracted the data. The primary outcome was the pooled completion rate of the 1BP protocols. Secondary outcomes compared safety, completion rates, and protocol duration between the 1BP and 3BP.</p><p><strong>Results: </strong>Our analysis of 16 studies included 975 patients undergoing 4,473 RDD procedures. The pooled completion rate for 1BP was 99.7% (95% CI: 99.35-99.9%; Prediction Interval: 98-100%), remaining consistent across drug classes. While BTR occurred in 12% of RDDs, they were predominantly mild to moderate, with only 0.4% being severe. In studies comparing protocols, there was no significant difference in completion rates (Risk Difference: 0.00; p = 0.966).</p><p><strong>Conclusion: </strong>One-bag RDD protocols demonstrate demonstrate consistent safety and completion rates. Our findings suggest that patient safety relies on the precise control of exposure kinetics rather than multiple dilution steps. By reducing procedural complexity and duration, 1BP provides a robust strategy to streamline workflows, optimize resource allocation, and enhance patient access to cancer therapies across diverse healthcare settings.</p><p><strong>Prospero registration: </strong>CRD42024586580.</p>","PeriodicalId":50773,"journal":{"name":"Annals of Allergy Asthma & Immunology","volume":" ","pages":""},"PeriodicalIF":5.8,"publicationDate":"2025-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144585544","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Severe asthma and new-onset meat allergy in a child-could a new puppy be to blame? 儿童出现严重哮喘和新出现的肉类过敏——新养的小狗是罪魁祸首吗?
IF 5.8 2区 医学
Annals of Allergy Asthma & Immunology Pub Date : 2025-07-02 DOI: 10.1016/j.anai.2025.06.033
Gauri Misra, Rebecca Grohman, Mikhail Kazachkov, Anna Nowak-Wegrzyn
{"title":"Severe asthma and new-onset meat allergy in a child-could a new puppy be to blame?","authors":"Gauri Misra, Rebecca Grohman, Mikhail Kazachkov, Anna Nowak-Wegrzyn","doi":"10.1016/j.anai.2025.06.033","DOIUrl":"https://doi.org/10.1016/j.anai.2025.06.033","url":null,"abstract":"","PeriodicalId":50773,"journal":{"name":"Annals of Allergy Asthma & Immunology","volume":" ","pages":""},"PeriodicalIF":5.8,"publicationDate":"2025-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144565445","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management of indolent mastocytosis and mast cell activation syndrome: A clinical yardstick. 慵懒肥大细胞增多症和肥大细胞活化综合征的处理:一个临床标准。
IF 5.8 2区 医学
Annals of Allergy Asthma & Immunology Pub Date : 2025-06-29 DOI: 10.1016/j.anai.2025.06.032
Cem Akin, Joseph H Butterfield, Mariana Castells, Jonathan J Lyons, Jay Lieberman
{"title":"Management of indolent mastocytosis and mast cell activation syndrome: A clinical yardstick.","authors":"Cem Akin, Joseph H Butterfield, Mariana Castells, Jonathan J Lyons, Jay Lieberman","doi":"10.1016/j.anai.2025.06.032","DOIUrl":"https://doi.org/10.1016/j.anai.2025.06.032","url":null,"abstract":"<p><p>Knowledge and understanding of mast cell biology and mast cell disorders has increased in the past several years, with new classifications of diseases for both clonal and non-clonal forms. Along with these classifications has come differing treatment paradigms, including novel therapies now approved for various forms of clonal mast cell disorders. Unfortunately, there is some lack of guidance on how best to utilize these therapies. This yardstick aims to provide the clinician with a review of available therapies to treat mast cell activation syndrome and indolent systemic mastocytosis and an evidence-based expert opinion approach regarding how best to utilize these therapies.</p>","PeriodicalId":50773,"journal":{"name":"Annals of Allergy Asthma & Immunology","volume":" ","pages":""},"PeriodicalIF":5.8,"publicationDate":"2025-06-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144545927","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Treating allergic rhinitis by thinking globally and acting locally 治疗变应性鼻炎要全局思考,局部行动
IF 5.8 2区 医学
Annals of Allergy Asthma & Immunology Pub Date : 2025-06-26 DOI: 10.1016/j.anai.2025.03.024
Marcus Shaker MD, MS , Larry Borish MD
{"title":"Treating allergic rhinitis by thinking globally and acting locally","authors":"Marcus Shaker MD, MS ,&nbsp;Larry Borish MD","doi":"10.1016/j.anai.2025.03.024","DOIUrl":"10.1016/j.anai.2025.03.024","url":null,"abstract":"","PeriodicalId":50773,"journal":{"name":"Annals of Allergy Asthma & Immunology","volume":"135 1","pages":"Pages 1-2"},"PeriodicalIF":5.8,"publicationDate":"2025-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144480606","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Weighing real-world studies when choosing a biologic for asthma 在选择治疗哮喘的生物制剂时,权衡现实世界的研究
IF 5.8 2区 医学
Annals of Allergy Asthma & Immunology Pub Date : 2025-06-26 DOI: 10.1016/j.anai.2025.04.004
Suzanne Y. Ngo MD , William C. Anderson III MD
{"title":"Weighing real-world studies when choosing a biologic for asthma","authors":"Suzanne Y. Ngo MD ,&nbsp;William C. Anderson III MD","doi":"10.1016/j.anai.2025.04.004","DOIUrl":"10.1016/j.anai.2025.04.004","url":null,"abstract":"","PeriodicalId":50773,"journal":{"name":"Annals of Allergy Asthma & Immunology","volume":"135 1","pages":"Pages 11-12"},"PeriodicalIF":5.8,"publicationDate":"2025-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144480761","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
From the pages of AllergyWatch 来自过敏症观察的页面
IF 5.8 2区 医学
Annals of Allergy Asthma & Immunology Pub Date : 2025-06-26 DOI: 10.1016/j.anai.2025.02.006
Stanley M. Fineman MD , Shyam R. Joshi MD , Iris Otani MD , Sarah Spriet DO
{"title":"From the pages of AllergyWatch","authors":"Stanley M. Fineman MD ,&nbsp;Shyam R. Joshi MD ,&nbsp;Iris Otani MD ,&nbsp;Sarah Spriet DO","doi":"10.1016/j.anai.2025.02.006","DOIUrl":"10.1016/j.anai.2025.02.006","url":null,"abstract":"","PeriodicalId":50773,"journal":{"name":"Annals of Allergy Asthma & Immunology","volume":"135 1","pages":"Pages 122-123"},"PeriodicalIF":5.8,"publicationDate":"2025-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144481043","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Information for Readers 读者资讯
IF 5.8 2区 医学
Annals of Allergy Asthma & Immunology Pub Date : 2025-06-26 DOI: 10.1016/S1081-1206(25)00254-6
{"title":"Information for Readers","authors":"","doi":"10.1016/S1081-1206(25)00254-6","DOIUrl":"10.1016/S1081-1206(25)00254-6","url":null,"abstract":"","PeriodicalId":50773,"journal":{"name":"Annals of Allergy Asthma & Immunology","volume":"135 1","pages":"Page A5"},"PeriodicalIF":5.8,"publicationDate":"2025-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144480603","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Incorporating Type-2 inflammation status with clinical diagnosis and transcriptomics data in asthma risk classification. 将2型炎症状态与临床诊断和转录组学数据结合起来进行哮喘风险分类。
IF 5.8 2区 医学
Annals of Allergy Asthma & Immunology Pub Date : 2025-06-26 DOI: 10.1016/j.anai.2025.06.029
Zi Ye, Solomon W Harrar, Joseph Beyene, Tesfaye B Mersha
{"title":"Incorporating Type-2 inflammation status with clinical diagnosis and transcriptomics data in asthma risk classification.","authors":"Zi Ye, Solomon W Harrar, Joseph Beyene, Tesfaye B Mersha","doi":"10.1016/j.anai.2025.06.029","DOIUrl":"https://doi.org/10.1016/j.anai.2025.06.029","url":null,"abstract":"<p><p>bronchial hyperresponsiveness (BHR), Immunoglobulin (IgE), skin prick test (SPT), T helper 2 (Th2), interleukin (IL), Type 2 inflammation (Th2), Area Under the Curve (AUC), Receiver Operating Characteristic (ROC), Genes-Environments and Admixture in Latino Americans (GALA II).</p>","PeriodicalId":50773,"journal":{"name":"Annals of Allergy Asthma & Immunology","volume":" ","pages":""},"PeriodicalIF":5.8,"publicationDate":"2025-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144530915","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Identifying patients with uncontrolled asthma or severe asthma 鉴别不受控制的哮喘或严重哮喘患者
IF 5.8 2区 医学
Annals of Allergy Asthma & Immunology Pub Date : 2025-06-26 DOI: 10.1016/j.anai.2025.05.002
Jerrius Jubran DO , Jonathan S. Tam MD
{"title":"Identifying patients with uncontrolled asthma or severe asthma","authors":"Jerrius Jubran DO ,&nbsp;Jonathan S. Tam MD","doi":"10.1016/j.anai.2025.05.002","DOIUrl":"10.1016/j.anai.2025.05.002","url":null,"abstract":"","PeriodicalId":50773,"journal":{"name":"Annals of Allergy Asthma & Immunology","volume":"135 1","pages":"Pages 13-14"},"PeriodicalIF":5.8,"publicationDate":"2025-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144480762","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信